Products:

Trinity EvidenceFirst™

Lowering the barriers to high-impact real-world evidence.

Home / Products / Trinity EvidenceFirstTM

Life sciences companies strive to make real-world evidence (RWE) a routine part of their decision-making process, but face challenges optimizing their use of real-world data (RWD).

Trinity’s EvidenceFirst offerings deliver meaningful RWE solutions by providing an experienced partner to work alongside life sciences leaders, with the context to flexibly implement built-for-purpose insights – and to draw on the appropriate data assets, from each company’s existing array of data resources to Trinity’s unique in-house data portfolio.

Trinity EvidenceFirst generates consistent, actionable real-world insights that ultimately allow life sciences organizations to answer critical questions, including:

  • Who are the patients?
  • Where do you find them?
  • How are they treated?
  • What are their outcomes?

With EvidenceFirst, life sciences companies can back commercial decision-making with real-world data (RWD) under circumstances and timeframes that previously were not realistic.

The EvidenceFirst Suite of Offerings

EvidenceFirst offerings align with and can be integrated with our best-in-class research and advisory services across Trinity’s Centers of Excellence.

Landscape Assessment, Early Asset / Portfolio Strategy

Landscape Assessment, Early Asset / Portfolio Strategy

RWE provides key market elements such as epidemiology, target specialties, and patient concentration to strengthen market understanding.

Market Map and Patient Journey

Market Map and Patient Journey

A holistic patient journey that brings together the voice of the patients with real-world data to quantify leverage points and understand the patient experience thoroughly

HCP Segmentation, KOL Mapping

HCP Segmentation, KOL Mapping

Segmentations linking primary and secondary data to connect physician behavior and sizing segments using RWD to create a more robust, actionable segmentation for maximum impact

Evidence Generation and Payer Value Proposition

Evidence Generation and Payer Value Proposition

Full suite of well-rounded value propositions from evaluation, planning to communication (publications, manuscripts, posters, etc.). RWE helps quantify value and drive such scientific communication.

Forecasting

Forecasting

RWD used to drive and validate assumptions (e.g., Epi, treatment rates, share, DOT, etc.)

Commercial Targeting

Commercial Targeting

RWE provides patient-level metrics (e.g., patient volume, treatment distribution, etc.) by HCP/Account to enhance targeting solutions and provides input into CRM and reporting platforms.

  • Analytical Methods

    Tailoring analytics to our clients’ needs.

    Each EvidenceFirst core offering can be augmented with bespoke analytics aligned to our client’s unique business goals and data needs. We leverage our custom capabilities, proven methodologies and industry expertise to deliver a depth and breadth of analytics to support your nuanced studies. Our dedicated RWE team has in-depth experience with >15 common industry and government datasets enabling us to match the right tool and approach to your needs.

  • How are Clients Leveraging EvidenceFirst™?
    • New Product Planning and Business Development: Provide insights into the market size and quantify key patterns within the patient population to identify who the patients are, who treats them, and how they are treated
    • Market Research and Brand Teams: Provide the understanding of the patient flow and quantify key patterns within the patient population to identify who the patients are, who treats them, and how they are being treated
    • Forecasting: Provide robust data to support model assumptions (e.g., market size, treatment rates, market share, days on therapy, etc.)
    • HEOR: Provide epidemiology and health care research utilization (HCRU) insights that support evidence generation plans

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.